Cargando…
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users
BACKGROUND: 3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death. We aimed to analyze the composition of the supposed 3-MMC samples purchased a...
Autores principales: | Willeman, Théo, Grundig, Nathan, Pochon, Christine, Michels, David, Charpentier, Nicolas, Eysseric-Guérin, Hélène, Fouilhé Sam-Lai, Nathalie, Stanke-Labesque, Françoise, Revol, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375651/ https://www.ncbi.nlm.nih.gov/pubmed/37507699 http://dx.doi.org/10.1186/s12954-023-00836-4 |
Ejemplares similares
-
Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register
por: Revol, Bruno, et al.
Publicado: (2023) -
Effects of 3-methylmethcathinone on conditioned place preference and anxiety-like behavior: Comparison with methamphetamine
por: Chen, Yang, et al.
Publicado: (2022) -
Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats
por: Šíchová, Klára, et al.
Publicado: (2018) -
Effect of Ambient Temperature on the Thermoregulatory and Locomotor Stimulant Effects of 4-Methylmethcathinone in Wistar and Sprague-Dawley Rats
por: Wright, M. Jerry, et al.
Publicado: (2012) -
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
por: Stanke-Labesque, Françoise, et al.
Publicado: (2020)